(Q39649740)

13 September 2017

1 reference

title

Application of recombinant DNA techniques in the development of viral vaccines (English)

1 reference

13 September 2017

Murray K

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 April 1988

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

164-174

1 reference

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

The molecular biology of the hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Hepatitis B virus genes and their expression in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Comparison of hepatitis B core antigens derived from human liver or synthesized in Escherichia coli and evaluation of their use in diagnostic assays for anti-HBc IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

The conversion of hepatitis B core antigen synthesized in E coli into e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Electron microscopy of hepatitis B core antigen synthesized in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Immunogenicity of recombinant yeast hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Hepatitis B and AIDS and the promise for their control by vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Expression of the X gene of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Possible role of immune responses to hepatitis B core antigen in protection against hepatitis B infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Protective immunisation against hepatitis B with an internal antigen of the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Comparative studies of the immunogenic activity of hepatitis B surface antigen (HBsAg) and HBsAg polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Hepatitis B polypeptide vaccine preparation in micelle form

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980022-7

7 January 2021

10.1016/S0264-410X(88)80022-7

Identifiers

DOI

1 reference

13 September 2017

1 reference